[Clinical course of hormone refractory cancer of the prostate].

Morote, J; Vila, J; López-Pacios, M A; De Torres, J A; Soler-Roselló, A

[Clinical course of hormone refractory cancer of the prostate]. / Evolución del cáncer de próstata hormonorrefractario.

Morote, J; Vila, J; López-Pacios, M A; De Torres, J A; Soler-Roselló, A.

Affiliation

Morote J; Servicio de Urología, Hospital Valle Hebrón, Barcelona.

Actas Urol Esp ; 16(9): 722-5, 1992 Oct.

Article in Es | MEDLINE | ID: mdl-1283286

Subject(s)

Estramustine/therapeutic use; Prostatic Neoplasms/therapy; Acid Phosphatase/blood; Actuarial Analysis; Androgen Antagonists/therapeutic use; Biomarkers, Tumor/blood; Diethylstilbestrol/therapeutic use; Humans; Male; Orchiectomy; Prostate; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Prostatic Neoplasms/mortality; Retrospective Studies; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Estramustine Type of study: Observational_studies / Screening_studies Limits: Humans / Male Language: Es Journal: Actas Urol Esp Year: 1992 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links